This is reported by TASS with reference to the press service of the Russian representative office of the company.

"Eli Lilly carries out and continues to supply vital medicines to the territory of the Russian Federation," the press service said.

It is also reported that Eli Lilly has entered into an agreement with the Swiss company Swixx Biopharma, providing for the transfer of rights to import the company's products, their sale in Russia, as well as the fulfillment of current obligations regarding local production.

It is noted that this agreement will allow the continued supply of vital medicines Eli Lilly to Russia for patients with diabetes, cancer, autoimmune and neurological diseases.

Earlier, Russian Health Minister Mikhail Murashko said that there is no global shortage of medicines in Russia, mechanisms have been developed and implemented to quickly solve difficulties.